Lynn Morris

Also affiliated with University of the Witwatersrand, Centre for the AIDS Programme of Research in South Africa

Immunology and MicrobiologySocial SciencesBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial”.

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody

medRxiv(2025)10.1101/2025.09.04.25334949

N/A

0DataRank · unranked

1 citations

Nonhlanhla N. Mkhize, Leonid Serebryannyy, Tandile Hermanus, Prudence Kgagudi, Haajira Kaldine +15 more